Show results for
Refine by
Chronic Disease Equipment Supplied In Canada
8 equipment items found
Manufactured by:Valeo Pharma Inc. based inKirkland, QUEBEC (CANADA)
Asthma is a chronic inflammatory disease that causes the airways in the lungs to narrow and swell. Symptoms include wheezing, breathlessness, chest tightness, cough and asthma attacks ...
Manufactured by:Bausch Health Companies Inc. based inLaval, QUEBEC (CANADA)
Our diversified portfolio of well-established specialty pharmaceuticals targets several therapeutic areas, including epilepsy, migraines, depression, chronic pain, and rare diseases such as Huntington's disease. ...
Manufactured by:Biotest AG based inDreieich, GERMANY
IgG Next Generation is a new development of a polyvalent immunglobulin (IVIG) for the treatment of immunedeficiencies and auto immune diseases. IgG Next Generation is being manufactured with a new and innovative production process and will be the main product of the new manufacturing site Biotest Next ...
Manufactured by:Biotest AG based inDreieich, GERMANY
IgG Next Generation is a new development of a polyvalent immungiobulin (NIG) for the treatment of immunedeficiencies and auto immune diseases. IgG Next Generation is manufactured with a new and innovative production process and will be the main product of the new manufacturing site Biotest Next ...
Manufactured by:Echosens based inParis, FRANCE
The complete non-invasive solution for advanced liver disease management. Powered by unique, patented and validated parameters: LSM by VCTE™, CAP™ and SSM by VCTE™ as part of an overall assessment of the ...
Manufactured by:Zoetis Services LLC based inParsippany, NEW JERSEY (USA)
With 30 years of use, DORMOSEDAN Sterile Solution (detomidine hydrochloride) provides veterinarians with safe and reliable sedation and analgesia1 that is rated highest of all equine sedatives for efficacy, safety and ...
Manufactured by:Nanostics Inc. based inEdmonton, ALBERTA (CANADA)
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare decisions. Validation of ClarityDX Prostate® is ongoing in a 2800 patient clinical study designed to meet regulatory ...
Manufactured by:Nanostics Inc. based inEdmonton, ALBERTA (CANADA)
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...